Testosterone cypionate (TRT)

Testosterone cypionate is a form of testosterone replacement therapy (TRT) used to treat hypogonadism, which can improve sexual function and overall well-being in men with low testosterone levels. Studies comparing different forms of TRT have found that testosterone cypionate administered intramuscularly can be as effective as other formulations like subcutaneous testosterone enanthate for treating symptoms of hypogonadism. Research also indicates that while testosterone therapy can benefit prostate cancer survivors experiencing hypogonadism, it may increase the risk of secondary polycythemia, a condition characterized by an elevated red blood cell count. Additionally, testosterone treatment has been linked to improvements in motor function among men with spinal cord injuries.

This form of TRT is connected to potential sexual dysfunction as a side effect, though the evidence for this connection comes from randomized controlled trials that are moderately strong. It's important to note that while there is research supporting the benefits and risks of testosterone cypionate, more studies would provide a clearer understanding of its long-term effects and optimal use in various patient populations.

Sources

• Comparison of Outcomes for Hypogonadal Men Treated with Intramuscular Testosterone Cypionate versus Subcutaneous Testosterone Enanthate. (PMID:34694927)
• A cross-sectional comparison of secondary polycythemia in testosterone-deficient men treated with nasal testosterone gel vs. intramuscular testosterone cypionate. (PMID:32744998)
• Testosterone Treatment in Prostate Cancer Survivors With Hypogonadism: A Randomized Clinical Trial. (PMID:42113507)
• Effects of orchiectomy and testosterone replacement therapy on redox balance and salivary gland function in Wistar rats. (PMID:34973376)
• Testosterone replacement therapy and motor function in men with spinal cord injury: a retrospective analysis. (PMID:18356620)
• Comparison of Intratesticular Testosterone between Men Receiving Nasal, Intramuscular, and Subcutaneous Pellet Testosterone Therapy: Evaluation of Data from Two Single-Center Randomized Clinical Trials. (PMID:35791295)

_Worker-drafted node, Hermes writer enrichment, pending editorial review._